Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_058e4c932dbfc13eba909846e15d9596 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2509-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0619 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0081 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0793 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 |
filingDate |
2019-04-26^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ca33a0313cb915dee0f80591d034863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73ab1d483131d6331c1f301da251620e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42afa64e969120bf6ec517dd5fe83735 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ef23f5bd38a4f882a1e78d64e9cc409 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60793554cda55ce8cdba51ecf31fe2ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_754b4f85b54b3558f22ffcb0f7d1c835 |
publicationDate |
2020-01-08^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3591039-A1 |
titleOfInvention |
Method for isolating dopamine neurons and pharmaceutical composition for treating parkinson's disease, containing dopamine neurons isolated using same |
abstract |
The present disclosure addresses a method for separating dopaminergic neural cells and a pharmaceutical composition comprising the dopaminergic neural cells separated by the method for treatment of Parkinson's disease, wherein the method for separating dopaminergic neural cells comprises a step of separating TPBG-positive dopaminergic neural cells, whereby the dopaminergic neural cells separated according to the method of the present invention are enhanced in efficacy for transplantation and have advanced transplantation safety and thus can find useful applications in transplantation for Parkinson's disease. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022221765-A1 |
priorityDate |
2018-05-02^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |